AstraZeneca PLC : A rally could take place
Entry price | Target | Stop-loss | Potential |
---|
GBX 3,920 |
GBX 0 |
GBX 3,845 |
-100% |
---|
AstraZeneca’s share price was heavily penalized and is now in an oversold situation near to a solid support area.
In the recent months, the earnings estimates for the next year are regularly revised upward by analysts.
Technically, in daily data, even if moving averages are still in a downtrend, a positive reaction in the GBp 3890 area should stop this trend and allow a technical rebound towards GBp 4076. Moreover, technical indicators show a significant oversold condition which strengthens this bullish scenario.
So as to make the most of a potential technical rebound of AstraZeneca, it seems opportune to open a long trade at current prices. A confirmation of this pattern would enable the security to reach the GBp 4205 resistance, with a potential gain of around 8%.
Investors should not insist under GBp 3890 and are better of placing a stop loss order under this threshold.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.